| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.3B | $11.0B | $9.0B | $7.2B | $5.9B | $4.5B | $3.5B | $2.6B |
| Cost of Revenue | $3.0B | $2.3B | $1.9B | $1.6B | $1.4B | $1.0B | $0.8B | $0.6B |
| Gross Profit | $10.3B | $8.7B | $7.0B | $5.7B | $4.5B | $3.5B | $2.7B | $2.0B |
| R&D Expense | $3.0B | $2.5B | $2.1B | $1.8B | $1.4B | $1.0B | $0.7B | $0.5B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.8B | $1.4B | $0.8B | $0.4B | $0.3B | $0.2B | $0.0B | $-0.0B |
| Net Income | $1.7B | $1.4B | $1.7B | $0.3B | $0.2B | $0.1B | $0.6B | $-0.0B |
| EPS (Basic) | $1.69 | $6.92 | $8.48 | $1.61 | $1.16 | $0.61 | $3.36 | — |
| EPS (Diluted) | $1.67 | $6.84 | $8.42 | $1.60 | $1.13 | $0.59 | $3.18 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.0B | $20.4B | $17.4B | $13.3B | $10.8B | $8.7B | $6.0B | $3.9B |
| Current Assets | $10.5B | $9.2B | $7.8B | $6.7B | $5.2B | $4.5B | $2.8B | $2.3B |
| Cash & Equivalents | $3.7B | $2.3B | $1.9B | $1.5B | $1.7B | $1.7B | $0.8B | $0.6B |
| Total Liabilities | $13.1B | $10.8B | $9.8B | $8.3B | $7.1B | $5.9B | $3.9B | $2.8B |
| Current Liabilities | $10.4B | $8.4B | $7.4B | $6.0B | $4.9B | $3.7B | $2.8B | $2.0B |
| Stockholders' Equity | $13.0B | $9.6B | $7.6B | $5.0B | $3.7B | $2.8B | $2.1B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.4B | $4.3B | $3.4B | $2.7B | $2.2B | $1.8B | $1.2B | $0.8B |
| Investing Cash Flow | $-1.7B | $-2.5B | $-2.2B | $-2.6B | $-1.6B | $-1.5B | $-0.7B | $-0.3B |
| Capital Expenditures | $0.9B | $0.9B | $0.7B | $0.6B | $0.4B | $0.4B | $0.3B | $0.2B |
| Financing Cash Flow | $-2.3B | $-1.3B | $-0.8B | $-0.3B | $-0.5B | $0.6B | $-0.3B | $-0.6B |